Out of 10,953 patients presently in the TCGA database, 422 patients have 458 ARHGAP35 mutations in tumor samples of which 103 mutations are recurrent; defined as three or more tumors with mutation of a given residue, excluding multiple samples from the same individual (cbioportal.org). Here, ARHGAP35 is linked to neoplasm.